Pages that link to "Q35165357"
Jump to navigation
Jump to search
The following pages link to Production of resistant HIV mutants during antiretroviral therapy (Q35165357):
Displaying 50 items.
- Modeling the within-host dynamics of HIV infection (Q21245370) (← links)
- The causes and consequences of HIV evolution (Q22251040) (← links)
- Evolutionary rescue: linking theory for conservation and medicine (Q26862297) (← links)
- Viral quasispecies evolution (Q27013917) (← links)
- Modeling antiretroviral drug responses for HIV-1 infected patients using differential equation models (Q27015861) (← links)
- Evolution of Resistant M414T Mutants among Hepatitis C Virus Replicon Cells Treated with Polymerase Inhibitor A-782759 (Q27480267) (← links)
- DPC 681 and DPC 684: potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variants (Q28361560) (← links)
- Optimal timing and duration of induction therapy for HIV-1 infection (Q28469250) (← links)
- Emergence of recombinant forms of HIV: dynamics and scaling (Q28469341) (← links)
- A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variants (Q28473678) (← links)
- Combination of two but not three current targeted drugs can improve therapy of chronic myeloid leukemia (Q28474737) (← links)
- Timing the emergence of resistance to anti-HIV drugs with large genetic barriers (Q28474857) (← links)
- A stochastic model of latently infected cell reactivation and viral blip generation in treated HIV patients (Q28477926) (← links)
- Evolutionary analysis of human immunodeficiency virus type 1 therapies based on conditionally replicating vectors (Q28484825) (← links)
- Rational Design and Adaptive Management of Combination Therapies for Hepatitis C Virus Infection (Q28545971) (← links)
- Residual Viremia in Treated HIV Individuals (Q28552126) (← links)
- The probability of evolutionary rescue: towards a quantitative comparison between theory and evolution experiments (Q28710078) (← links)
- Cancer in light of experimental evolution (Q28727500) (← links)
- Escherichia coli resistance to nonbiocidal antibiofilm polysaccharides is rare and mediated by multiple mutations leading to surface physicochemical modifications (Q30541729) (← links)
- Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo (Q33455862) (← links)
- Computational models of HIV-1 resistance to gene therapy elucidate therapy design principles (Q33658642) (← links)
- Modeling-error robustness of a viral-load preconditioning strategy for HIV treatment switching. (Q33771799) (← links)
- Stochastic Theory of Early Viral Infection: Continuous versus Burst Production of Virions (Q33815539) (← links)
- HIV sequence variation associated with env antisense adoptive T-cell therapy in the hNSG mouse model (Q33822232) (← links)
- Drug resistance in cancer: principles of emergence and prevention (Q33892278) (← links)
- Genotypic testing for human immunodeficiency virus type 1 drug resistance (Q33906239) (← links)
- Quantification of intrinsic residual viral replication in treated HIV-infected patients (Q33953001) (← links)
- Optimal antiviral switching to minimize resistance risk in HIV therapy (Q34071754) (← links)
- Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1 (Q34092679) (← links)
- Resistance evolution in HIV - modeling when to intervene (Q34247013) (← links)
- HIV-1 Diversity After a Class Switch Failure (Q34399268) (← links)
- Virus population dynamics, fitness variations and the control of viral disease: an update (Q34452529) (← links)
- Systems mapping of HIV-1 infection (Q34455661) (← links)
- Targeting HIV: antiretroviral therapy and development of drug resistance. (Q34960413) (← links)
- Quantifying the fitness advantage of polymerase substitutions in Influenza A/H7N9 viruses during adaptation to humans (Q35006157) (← links)
- Natural polymorphisms and unusual mutations in HIV-1 protease with potential antiretroviral resistance: a bioinformatic analysis. (Q35120811) (← links)
- Tempo and mode of inhibitor-mutagen antiviral therapies: a multidisciplinary approach (Q35229409) (← links)
- Simple mathematical models do not accurately predict early SIV dynamics (Q35232811) (← links)
- Combination versus sequential monotherapy in chronic HBV infection: a mathematical approach. (Q35422530) (← links)
- A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies (Q35742512) (← links)
- Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy (Q36091918) (← links)
- HIV therapy: managing resistance (Q36104156) (← links)
- Genetic drift and within-host metapopulation dynamics of HIV-1 infection (Q36259922) (← links)
- Impact of mupirocin resistance on the transmission and control of healthcare-associated MRSA (Q36298961) (← links)
- Robust closed-loop minimal sampling method for HIV therapy switching strategies. (Q36306340) (← links)
- Accurate predictions of population-level changes in sequence and structural properties of HIV-1 Env using a volatility-controlled diffusion model. (Q36337888) (← links)
- Stochastic effects are important in intrahost HIV evolution even when viral loads are high (Q36438430) (← links)
- Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection (Q36464609) (← links)
- Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility (Q36492224) (← links)
- HIV recombination: what is the impact on antiretroviral therapy? (Q36539852) (← links)